Gwo Xi Stem Cell Applied Technology Co. , Ltd (TPEX:6704)
25.00
-0.10 (-0.40%)
Jan 21, 2026, 1:21 PM CST
TPEX:6704 Revenue
Gwo Xi Stem Cell Applied Technology Co. , had revenue of 94.49M TWD in the half year ending June 30, 2025, with 34.44% growth. This brings the company's revenue in the last twelve months to 184.91M, up 22.87% year-over-year. In the year 2024, Gwo Xi Stem Cell Applied Technology Co. , had annual revenue of 170.03M with 20.44% growth.
Revenue (ttm)
184.91M
Revenue Growth
+22.87%
P/S Ratio
13.02
Revenue / Employee
n/a
Employees
34
Market Cap
2.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 170.03M | 28.85M | 20.44% |
| Dec 31, 2023 | 141.18M | -39.49M | -21.86% |
| Dec 31, 2022 | 180.67M | -62.09M | -25.58% |
| Dec 31, 2021 | 242.75M | 54.21M | 28.75% |
| Dec 31, 2020 | 188.54M | 11.86M | 6.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |
| Caliway Biopharmaceuticals | 34.99M |